MAPT and Alzheimer disease: Recently, Giraldo-Berrio et al. [73] investigated the interference of minocycline with different aspects of the pathophysiology of AD, including acetylcholine release, tau and β-amyloid aggregation, in cholinergic-like neurons derived from mesenchymal cells with and without a presenilin 1 mutation associated with AD.